Skip to main content

Off-patent Drugs Bill

Private Members' Bill (Ballot Bill)

Originated in the House of Commons, session 2014-15

Last updated: 30 March 2015 at 14:51

See full passage

Long title

A Bill to require the Secretary of State to take steps to secure licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.

Sponsor

Jonathan Evans
Conservative
Cardiff North

Current version of the Bill

29 October 2014
Commons

Bill passage

Bill started in the House of Commons
1st reading
Committee stage
Report stage
3rd reading
Bill in the House of Lords
1st reading
2nd reading
Committee stage
Report stage
3rd reading
Final stages
Consideration of amendments
Royal Assent
Key
Complete
In progress
Not applicable
Not yet reached